These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31218536)

  • 1. Modeling human disease in yeast: recreating the PI3K-PTEN-Akt signaling pathway in Saccharomyces cerevisiae.
    Coronas-Serna JM; Valenti M; Del Val E; Fernández-Acero T; Rodríguez-Escudero I; Mingo J; Luna S; Torices L; Pulido R; Molina M; Cid VJ
    Int Microbiol; 2020 Jan; 23(1):75-87. PubMed ID: 31218536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast.
    Cid VJ; Rodríguez-Escudero I; Andrés-Pons A; Romá-Mateo C; Gil A; den Hertog J; Molina M; Pulido R
    Oncogene; 2008 Sep; 27(41):5431-42. PubMed ID: 18794878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI(3)king apart PTEN's role in cancer.
    Zhang S; Yu D
    Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
    Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
    Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
    Andrés-Pons A; Rodríguez-Escudero I; Gil A; Blanco A; Vega A; Molina M; Pulido R; Cid VJ
    Cancer Res; 2007 Oct; 67(20):9731-9. PubMed ID: 17942903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.
    Andersen JN; Sathyanarayanan S; Di Bacco A; Chi A; Zhang T; Chen AH; Dolinski B; Kraus M; Roberts B; Arthur W; Klinghoffer RA; Gargano D; Li L; Feldman I; Lynch B; Rush J; Hendrickson RC; Blume-Jensen P; Paweletz CP
    Sci Transl Med; 2010 Aug; 2(43):43ra55. PubMed ID: 20686178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y; Huang H
    Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
    Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
    Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.
    Liu S; Wang XJ; Liu Y; Cui YF
    Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
    Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
    Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway.
    Wu B; Wang X; Chi ZF; Hu R; Zhang R; Yang W; Liu ZG
    Arch Pharm Res; 2012 Mar; 35(3):543-8. PubMed ID: 22477202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.
    Vivanco I; Palaskas N; Tran C; Finn SP; Getz G; Kennedy NJ; Jiao J; Rose J; Xie W; Loda M; Golub T; Mellinghoff IK; Davis RJ; Wu H; Sawyers CL
    Cancer Cell; 2007 Jun; 11(6):555-69. PubMed ID: 17560336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.
    Du J; Wang L; Li C; Yang H; Li Y; Hu H; Li H; Zhang Z
    Tumour Biol; 2016 Mar; 37(3):3939-47. PubMed ID: 26482612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of maternal phosphatidylinositol 3 kinase (PI3K) signaling in manipulating mammalian preimplantation embryogenesis.
    Zheng W; Liu K
    Cell Cycle; 2011 Jan; 10(2):178-9. PubMed ID: 21239876
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.
    Fu Z; Ren L; Wei H; Lv J; Che X; Zhu Z; Jia J; Wang L; Lin G; Lu R; Yao Z
    J Drug Target; 2014 Feb; 22(2):146-55. PubMed ID: 24147456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.